Millipore Sigma Vibrant Logo

370677 Guanosine 3ʹ,5ʹ-cyclic Monophosphorothioate, 8-(4-Chlorophenylthio)-, Rp-Isomer, Triethylammonium Salt - Calbiochem

A potent, cell-permeable, and metabolically-stable inhibitor of protein kinase G Iα, Iβ, and type II.

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: Rp-8-pCPT-cGMPS, TEA, PKG Inhibitor III

Primary Target: PKG1α
View Products on Sigmaaldrich.com
370677
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

Empirical Formula
C₁₆H₁₅ClN₅O₆PS₂ · C₆H₁₅N

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
370677-1UMOL
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Ampoule plast. 1 umol
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewA potent, cell-permeable, and metabolically-stable inhibitor of protein kinase G Iα, Iβ, and type II. Significantly more lipophilic and membrane-permeable than Rp-cGMPS or Rp-8-Br-cGMPS (Cat. No. 370674). Note: 1 µmol = 0.61 mg.
      Catalogue Number370677
      Brand Family Calbiochem®
      SynonymsRp-8-pCPT-cGMPS, TEA, PKG Inhibitor III
      References
      ReferencesAbd Alla, S., et al. 1996. Eur. J. Biochem. 241, 498.
      Lee, S.J., et al. 1996. Dev. Biol. 180, 324.
      Van Uffelen, B.E., et al. 1996. J. Leukoc. Biol. 60, 94.
      Willmott, N., et al. 1996. J. Biol. Chem. 271, 3699.
      Butt, E., et al. 1994. Eur. J. Pharmacol. 269, 265.
      Product Information
      ATP CompetitiveN
      DeclarationSold under license of U.S. Patent 5,625,056, Patents DE 3,802,865.4, and DE 4,217,679 issued to BIOLOG LSI.
      FormLyophilized
      Hill FormulaC₁₆H₁₅ClN₅O₆PS₂ · C₆H₁₅N
      Chemical formulaC₁₆H₁₅ClN₅O₆PS₂ · C₆H₁₅N
      Hygroscopic Hygroscopic
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPKG1α
      Purity≥99% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      370677-1UMOL 04055977191707

      Documentation

      Required Licenses

      Title
      PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

      Guanosine 3ʹ,5ʹ-cyclic Monophosphorothioate, 8-(4-Chlorophenylthio)-, Rp-Isomer, Triethylammonium Salt - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Guanosine 3ʹ,5ʹ-cyclic Monophosphorothioate, 8-(4-Chlorophenylthio)-, Rp-Isomer, Triethylammonium Salt - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      370677

      Références bibliographiques

      Aperçu de la référence bibliographique
      Abd Alla, S., et al. 1996. Eur. J. Biochem. 241, 498.
      Lee, S.J., et al. 1996. Dev. Biol. 180, 324.
      Van Uffelen, B.E., et al. 1996. J. Leukoc. Biol. 60, 94.
      Willmott, N., et al. 1996. J. Biol. Chem. 271, 3699.
      Butt, E., et al. 1994. Eur. J. Pharmacol. 269, 265.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision07-July-2008 RFH
      SynonymsRp-8-pCPT-cGMPS, TEA, PKG Inhibitor III
      DescriptionA potent, cell-permeable inhibitor of protein kinase G Iα, Iβ, and type II. A combination of the protein kinase inhibitor Rp-cGMPS and the widely used cGMP analog, 8-pCPT-cGMP. Significantly more lipophilic and membrane-permeant than Rp-cGMPS and Rp-8-Br-cGMPS. Resistant to hydrolysis by mammalian cyclic nucleotide dependent phosphodiesterases. Note: 1 µmol = 0.61 mg.
      FormLyophilized
      Chemical formulaC₁₆H₁₅ClN₅O₆PS₂ · C₆H₁₅N
      Structure formulaStructure formula
      Purity≥99% by HPLC
      SolubilityDMSO or H₂O (0.5 mg/ml)
      Storage -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesAbd Alla, S., et al. 1996. Eur. J. Biochem. 241, 498.
      Lee, S.J., et al. 1996. Dev. Biol. 180, 324.
      Van Uffelen, B.E., et al. 1996. J. Leukoc. Biol. 60, 94.
      Willmott, N., et al. 1996. J. Biol. Chem. 271, 3699.
      Butt, E., et al. 1994. Eur. J. Pharmacol. 269, 265.